Back to XENE
T. Rowe Price Investment Management, Inc. → XENE
T. Rowe Price Investment Management, Inc. XENE Position History
Xenon Pharmaceuticals Inc. • Healthcare
Quarters held
5
Latest value
$293.7M
Q3 2026
Peak value
$293.7M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $4.1M |
| Q4 2025 | $24.5M |
| Q1 2026 | $55.4M |
| Q2 2026 | $130.9M |
| Q3 2026 | $293.7M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $293.7M | 7.90M | — | — |
| Q2 2026 | $130.9M | 2.17M | — | — |
| Q1 2026 | $55.4M | 952.0K | — | — |
| Q4 2025 | $24.5M | 547.6K | — | — |
| Q4 2025 | $4.1M | 92.5K | — | — |
Other funds holding XENE
$413.3M
$405.6M
$348.7M
$278M
$275.9M